Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-PAM Antibody (R3F13)

Catalog #:   RHD31801 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC, WB
Accession: P19021
Overview

Catalog No.

RHD31801

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:50, WB: 1:500-1:1000

Target

PAL, PHM, PAM, Peptidylamidoglycolate lyase, Peptidyl-glycine alpha-amidating monooxygenase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P19021

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3F13

Data Image
  • Immunohistochemical
    IHC-P analysis of heart muscle tissue by PAM antibody (RHD31801). IHC-P was performed using sections of the formalin-fixed paraffin-embedded heart muscle tissue;Result: Cardiomyocytes are positively stained at the cytoplasm.
  • Western blot
    Western blot analysis using PAM mouse mAb against U-251MG lysate
References

Advances in the treatment of ANCA-associated vasculitis., PMID:40473820

pH-Responsive Diblock Copolymer Vesicles via Polymerization-Induced Self-Assembly in Aqueous Media: Synthesis, Loading, and Potential Biological Applications., PMID:40460265

A Spanish Porcine Reproductive and Respiratory Syndrome Virus 1 Strain Is Highly Virulent in Pigs Under Experimental Conditions., PMID:40453458

Efficient Design of Affilin® Protein Binders for HER3., PMID:40429825

Exploring In Vivo Metal Chelation as an Approach for Pretargeted PET Imaging., PMID:40415838

Synthesis of the Pentasaccharide Unit of the Pseudomonas aeruginosa Exopolysaccharide Psl Conjugation with CRM197, and Evaluation of Antigenicity in a QS-21/Pam3CSK4-Liposomal Formulation., PMID:40333663

Adjuvant Templating Improves On-Target/Off-Target Antibody Ratio Better than Linker Addition for M2-Derived Peptide Amphiphile Micelle Vaccines., PMID:40333333

Activation of Marck-like Genes and Proteins During Initial Phases of Regeneration in the Amputated Tail and Limb of the Lizard Podarcis muralis., PMID:40265370

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial., PMID:40154210

Endothelial JCAD Worsens Acute Ischemic Stroke Outcomes by Enhancing Inflammation in Response to Ischemia/Reperfusion., PMID:40131119

Inflammation-Driven Plaque Erosion in Atherosclerosis: A Focus on Complement System Pathways., PMID:40119227

Identification of Naegleria fowleri antigens recognized by serum antibodies from people of Mexicali Valley, México., PMID:40088312

[ANCA-associated vasculitides: what nephrologists need to know]., PMID:39917792

Rapid and specific on-site H5Nx avian influenza diagnosis via RPA and PAM-independent CRISPR-Cas12a assay combined with anti-NP antibody-based viral RNA purification., PMID:39896844

Toll-like receptor 1/2 activation reduces immunoglobulin free light chain production by multiple myeloma cells in the context of bone marrow stromal cells and fibronectin., PMID:39874349

Peptide Antigen Modifications Influence the On-Target and Off-Target Antibody Response for an Influenza Subunit Vaccine., PMID:39852830

Colchicine in Coronary Artery Disease: Where Do We Stand?, PMID:39847601

Comparative evaluation of funduscopy, PCR and serology in the diagnosis of ocular toxoplasmosis at ECWA Eye Hospital, Kano., PMID:39837789

Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT., PMID:39814869

Seroprevalence of Naegleria fowleri in the Houston-Galveston Texas Population., PMID:39729228

Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis., PMID:39719005

Rationalizing hydrogel-integrated peroxidase-mimicking nanozymes for combating drug-resistant bacteria and colorimetric sensing., PMID:39674468

Understanding the pathogenicity of Naegleria fowleri in association with N. fowleri antigen-1 (Nfa1)., PMID:39622651

Development and characterization of high-efficiency cell-adapted live attenuated vaccine candidate against African swine fever., PMID:39584308

Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD., PMID:39561307

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants., PMID:39553825

Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study., PMID:39549837

Detailed functional characterization of four nanobodies as positive allosteric modulators of the human calcium-sensing receptor., PMID:39522703

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies., PMID:39442037

Analysis of virulence factors in extracellular vesicles secreted by Naegleria fowleri., PMID:39432113

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma., PMID:39405335

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial., PMID:39379705

Therapeutic glycan-specific antibody binding mediates protection during primary amoebic meningoencephalitis., PMID:39235225

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study., PMID:39231582

Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study., PMID:39223063

Identification and Characterization of a Novel B Cell Epitope of ASFV Virulence Protein B125R Monoclonal Antibody., PMID:39205231

Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer's Disease., PMID:39204102

Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2., PMID:39196071

Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses., PMID:39154056

Distinct maturation, glucose metabolism, and inflammatory function of human monocytes-derived IDECs mediated by anti-IgE and Pam3CSK4 alone or in combination., PMID:39086490

Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease., PMID:39073291

PRRSV infection facilitates the shedding of soluble CD163 to induce inflammatory responses., PMID:39047452

Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma., PMID:39039666

Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy., PMID:38921797

An interpretable cluster-based logistic regression model, with application to the characterization of response to therapy in severe eosinophilic asthma., PMID:38910330

Severe infections in systemic necrotizing vasculitis., PMID:38821740

Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination., PMID:38791279

Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes., PMID:38739545

Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis., PMID:38688690

TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation., PMID:38629913

Datasheet

Document Download

Anti-PAM Antibody (R3F13).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-PAM Antibody (R3F13) [RHD31801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only